NEW YORK, Jan 19 - With the sale of over 60 MegaBace DNA analysis systems to research institutes in China and Brazil, Amersham Pharmacia Biotech said Friday that it is poised to dominate these markets.

These sales give AP Biotech “a market leading position” in the Latin American and Asia Pacific high-throughput sequencing markets, said Tracy Cheung, vice president of investo

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

US Attorney General Jeff Sessions is considering using DNA tests to determine relatedness between adult and child migrants, the Daily Caller reports.

Bloomberg reports that Brainstorm Cell Therapeutics plans to offer a treatment it is developing under the "right to try" law for hundreds of thousands of dollars.

In a proof-of-concept study, researchers report being able to determine age from dried bloodstains, Discover's D-brief blog reports.

In Nature this week: expansion of disease-resistance genes among long-lived oak trees, and more.